Cargando…

Developing of Granulomatosis with Polyangiitis during Etanercept Therapy

We describe a 67-year-old woman who developed c-ANCA positive vasculitis with involvement in eyes, skin, kidney, peripheral nerves, and upper and lower airway during treatment with etanercept therapy for rheumatoid arthritis. A diagnosis of Granulomatosis with Polyangiitis was done. Thus, anti-TNF t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortiz-Sierra, María Clara, Echeverri, Andrés Felipe, Tobón, Gabriel J., Cañas, Carlos Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965911/
https://www.ncbi.nlm.nih.gov/pubmed/24707429
http://dx.doi.org/10.1155/2014/210108
_version_ 1782308855339810816
author Ortiz-Sierra, María Clara
Echeverri, Andrés Felipe
Tobón, Gabriel J.
Cañas, Carlos Alberto
author_facet Ortiz-Sierra, María Clara
Echeverri, Andrés Felipe
Tobón, Gabriel J.
Cañas, Carlos Alberto
author_sort Ortiz-Sierra, María Clara
collection PubMed
description We describe a 67-year-old woman who developed c-ANCA positive vasculitis with involvement in eyes, skin, kidney, peripheral nerves, and upper and lower airway during treatment with etanercept therapy for rheumatoid arthritis. A diagnosis of Granulomatosis with Polyangiitis was done. Thus, anti-TNF therapy may be associated with the development of ANCA positive vasculitis.
format Online
Article
Text
id pubmed-3965911
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-39659112014-04-06 Developing of Granulomatosis with Polyangiitis during Etanercept Therapy Ortiz-Sierra, María Clara Echeverri, Andrés Felipe Tobón, Gabriel J. Cañas, Carlos Alberto Case Rep Rheumatol Case Report We describe a 67-year-old woman who developed c-ANCA positive vasculitis with involvement in eyes, skin, kidney, peripheral nerves, and upper and lower airway during treatment with etanercept therapy for rheumatoid arthritis. A diagnosis of Granulomatosis with Polyangiitis was done. Thus, anti-TNF therapy may be associated with the development of ANCA positive vasculitis. Hindawi Publishing Corporation 2014 2014-03-06 /pmc/articles/PMC3965911/ /pubmed/24707429 http://dx.doi.org/10.1155/2014/210108 Text en Copyright © 2014 María Clara Ortiz-Sierra et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Ortiz-Sierra, María Clara
Echeverri, Andrés Felipe
Tobón, Gabriel J.
Cañas, Carlos Alberto
Developing of Granulomatosis with Polyangiitis during Etanercept Therapy
title Developing of Granulomatosis with Polyangiitis during Etanercept Therapy
title_full Developing of Granulomatosis with Polyangiitis during Etanercept Therapy
title_fullStr Developing of Granulomatosis with Polyangiitis during Etanercept Therapy
title_full_unstemmed Developing of Granulomatosis with Polyangiitis during Etanercept Therapy
title_short Developing of Granulomatosis with Polyangiitis during Etanercept Therapy
title_sort developing of granulomatosis with polyangiitis during etanercept therapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965911/
https://www.ncbi.nlm.nih.gov/pubmed/24707429
http://dx.doi.org/10.1155/2014/210108
work_keys_str_mv AT ortizsierramariaclara developingofgranulomatosiswithpolyangiitisduringetanercepttherapy
AT echeverriandresfelipe developingofgranulomatosiswithpolyangiitisduringetanercepttherapy
AT tobongabrielj developingofgranulomatosiswithpolyangiitisduringetanercepttherapy
AT canascarlosalberto developingofgranulomatosiswithpolyangiitisduringetanercepttherapy